Cat. No.: DIA-0243211
Product Information | |
---|---|
Synonyms | Human N-acetyl GIP TFA |
Formula | C228H340N60O67S.C2HF3O2 |
Molecular Weight | 5139.62 |
Target | Insulin Receptor |
Product Description | Acetyl Gastric Inhibitory Peptide (human) TFA is a fatty acid derivatized analog of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties. Acetyl Gastric Inhibitory Peptide (human) TFA can be used for research of diabetes, insulin resistance and obesity. |
Format & Storage | |
---|---|
Format | Solid |
Color | White to off-white |
Purity | 99.70% |
Shipping | Room temperature in the continental U.S. Other areas may vary. |
Storage | In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Solubility Overview | Soluble in water |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.